Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency
/in International Publications, NSCLCTherapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours
/in Cervical Cancer, Dendritic Cells, International PublicationsMelanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells
/in International Publications, Malignant Melanoma[Active immunotherapy of prostate cancer with a focus on dendritic cells]
/in International Publications, Prostate CancerIntratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
/in Dendritic Cells, Hyperthermia, International Publications, Malignant MelanomaReversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil
/in Breast Cancer, Hyperthermia, International PublicationsDendritic cells and T lymphocyte interactions in patients with lymphoid malignancies
/in Chronic Leukemia, International Publications, Malignant LymphomaImmunological response in the mouse melanoma model after local hyperthermia
/in Hyperthermia, International Publications, Malignant MelanomaSpontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer
/in Hepatocellular Carcinoma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer